Zobrazeno 1 - 10
of 13
pro vyhledávání: '"Brittany N. Bohinc"'
Autor:
Anna Mae Diehl, Gregory A. Michelotti, Cynthia D. Guy, Thiago A. Pereira, Mariana Verdelho Machado, Ann Marie Zavacki, Dawn Piercy, Leandi Krüger, Manal F. Abdelmalek, Brittany N. Bohinc, Herbert Pang, Guanhua Xie, Marzena Swiderska-Syn, Ayako Suzuki
Publikováno v:
Endocrinology
Thyroid hormone (TH) is important for tissue repair because it regulates cellular differentiation. Intrahepatic TH activity is controlled by both serum TH levels and hepatic deiodinases. TH substrate (T4) is converted into active hormone (T3) by deio
Publikováno v:
Current Opinion in Oncology. 26:31-35
The incidence of well differentiated thyroid cancer (WDTC) is increasing in the US population and is now a major public health concern. Although surgery is the mainstay of treatment, radioactive iodine (RAI) is routinely used for adjuvant therapy, re
Autor:
Anna Mae Diehl, Brittany N. Bohinc
Publikováno v:
Clinics in Liver Disease. 16:549-565
The incidence of nonalcoholic fatty liver disease is increasing at an astonishing rate in the US population. Although only a small proportion of these patients develop steatohepatitis (NASH), those who do have a greater likelihood of developing end-s
Autor:
John F. Turner, William W. Hope, Ricardo V. Lloyd, Brittany N. Bohinc, Wanli Cheng, Cyrus A. Kotwall, John C. Parker
Publikováno v:
Thyroid. 21:1033-1038
Ectopic thyroid tissue is a rare finding but has been reported in many thoracic and abdominal locations. It is usually an incidental pathologic finding after an unrelated surgical intervention. When thyroid tissue is found outside the thyroid bed, it
Autor:
Diane Gesty-Palmer, Brittany N. Bohinc
Publikováno v:
Endocrine, Metabolic & Immune Disorders - Drug Targets. 11:112-119
Parathyroid hormone (PTH) is a principle regulator of bone and calcium metabolism and PTH analogs hold great promise as a therapy for metabolic bone diseases such as osteoporosis. PTH acts principally through the type IPTH/PTH-related peptide recepto
Autor:
Leandi Krüger, Brittany N. Bohinc, Cynthia D. Guy, Guanhua Xie, Marzena Swiderska-Syn, Erika Segear Johnson, Sally Kornbluth, T. De Almeida Pereira, Mariana Verdelho Machado, Kelly R. Lindblom, Anna Mae Diehl, Gregory A. Michelotti, Jérôme Boursier, Gamze Karaca
Publikováno v:
Gut
Gut, BMJ Publishing Group, 2015, 64 (7), pp.1148-1157. ⟨10.1136/gutjnl-2014-307362⟩
Gut, BMJ Publishing Group, 2015, 64 (7), pp.1148-1157. ⟨10.1136/gutjnl-2014-307362⟩
International audience; OBJECTIVE: Caspase-2 is an initiator caspase involved in multiple apoptotic pathways, particularly in response to specific intracellular stressors (eg, DNA damage, ER stress). We recently reported that caspase-2 was pivotal fo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e19b8b9e765c8c448b92a2035ffcdc10
https://hal.archives-ouvertes.fr/hal-01392300
https://hal.archives-ouvertes.fr/hal-01392300
Publikováno v:
Progress in molecular biology and translational science. 118
Parathyroid hormone (PTH) is the principle regulator of calcium-phosphorus metabolism and bone turnover. Because of its central role in bone remodeling, recombinant human PTH (i.e., Forteo®; PTH(1-34)) has been developed for the treatment of osteopo
Publikováno v:
Thyroid : official journal of the American Thyroid Association. 23(9)
Locally or widely metastatic medullary thyroid carcinoma (MTC) is difficult to treat, and therapeutic options are limited. Recently, kinase inhibitors have shown partial efficacy in this cancer, but there is a continued need for the development of no
Autor:
Diane Gesty-Palmer, Brittany N. Bohinc
Parathyroid hormone (PTH) is the principle regulator of calcium-phosphorus metabolism and bone turnover. Because of its central role in bone remodeling, recombinant human PTH (i.e., Forteo®; PTH(1-34)) has been developed for the treatment of osteopo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0b8c6d3b7840aba3c28cc1921e0988b3
https://doi.org/10.1016/b978-0-12-394440-5.00013-9
https://doi.org/10.1016/b978-0-12-394440-5.00013-9
Autor:
Brittany N, Bohinc, Anna Mae, Diehl
Publikováno v:
Clinics in liver disease. 16(3)
The incidence of nonalcoholic fatty liver disease is increasing at an astonishing rate in the US population. Although only a small proportion of these patients develop steatohepatitis (NASH), those who do have a greater likelihood of developing end-s